The exact mechanism of MEK4 in tumorigenesis is contentious given its effector JNK’s pro- and anti-oncogenic role; however most agree that it primarily functions as a tumor suppressor, with a significant reduction in survival observed in a variety of solid tumors with the loss of MKK4 [93,94,95]. The gene discussed is MAP2K4; the disease is neoplasm.